2024 Update: Critical Pharmaceutical Calculations for Non-Sterile Compounding

This presentation focuses on critical calculations essential for non-sterile pharmacy compounding, emphasizing three key learning objectives. Participants will calculate the precise quantity of active pharmaceutical ingredients (APIs) required in a non-sterile compound using aliquots, understand salt form corrections in non-sterile compounding, and develop an aggregate assay correction strategy based on the API's certificate of analysis.

Overall, this presentation equips compounding professionals with the knowledge and skills required for precise non-sterile compounding, enhancing their proficiency in critical calculations and ensuring the safety and efficacy of compounded pharmaceuticals.

At the completion of this activity, the participant should be able to:

  • Calculate the quantity of active pharmaceutical ingredients needed in a non-sterile compound using aliquots
  • Describe salt form corrections needed for a non-sterile compound
  • Develop an aggregate assay correction based on the active pharmaceutical ingredient's certificate of analysis

Presenter

Omar Allibhai, PharmD, RPh, FACA, FAPC a licensed pharmacist at Johnson Compounding & Wellness. He holds the distinction of being the first pharmacist to complete a groundbreaking two-year post-doctoral fellowship in pharmacy compounding nationwide. He received his PharmD and a certificate in radiopharmacy from MCPHS.

In his multifaceted role, Omar oversees diverse aspects of the pharmacy operation, including non-sterile compounding, formulation development, employee training, and the implementation of quality assurance programs.

He is a member of professional associations including the Massachusetts Independent Pharmacists Association, Massachusetts Pharmacist Association, Alliance for Pharmacy Compounding, American College of Apothecaries, and Johnson Compounding and Wellness's Quality Assurance team.

Registration Fee: Free for MCPHS alumni and full-time staff; $12.00 for all other professionals.

Release Date: June 7, 2024
Expiration Date: June 6, 2025
ACPE UAN:0026-0000-24-016-H03-P | Knowledge
ACPE Topic Designator: Pharmacy Law
Contact Hours: 1.0 (0.1 CEU)

Our CE is considered for both compounding and law credit in Massachusetts. The compounding modules are designated as law (03); however, they count for compounding (07) as well due to the titling and learning objectives as indicated in MA BOP Policy 2021-04: Continuing Education (CE) Requirements.

CE programs that cover the regulatory component of compounding are acceptable to fulfill the requirement for both compounding and law contact hours as long as the regulatory component is approved as a “law” CE program and the compounding component meets the acceptable program criteria set forth above.

Accreditation Council for Pharmacy Education Logo

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this educational activity for a total of 1.0 contact hours (0.1 CEUs).

In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion, participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.

Omar Allibhai has no financial relationships with ineligible companies to disclose.

Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.

No funding from industry provided for this event. No exhibitors will be present.